Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice
- PMID: 17588756
- PMCID: PMC2706264
- DOI: 10.1016/j.nmd.2007.04.008
Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice
Abstract
Duchenne muscular dystrophy (DMD) is a fatal neuromuscular human disease caused by dystrophin deficiency. The mdx mouse lacks dystrophin protein, yet does not exhibit the debilitating DMD phenotype. Investigating compensatory mechanisms in the mdx mouse may shed new insights into modifying DMD pathogenesis. This study targets two metabolic genes, guanidinoacetate methyltransferase (GAMT) and arginine:glycine amidinotransferase (AGAT) which are required for creatine synthesis. We show that GAMT and AGAT mRNA are up-regulated 5.4- and 1.9-fold respectively in adult mdx muscle compared to C57. In addition, GAMT protein expression is up-regulated at least 2.5-fold in five different muscles of mdx vs. control. Furthermore, we find GAMT immunoreactivity in up to 80% of mature mdx muscle fibers in addition to small regenerating fibers and rare revertants; while GAMT immunoreactivity is equal to background levels in all muscle fibers of mature C57 mice. The up-regulation of the creatine synthetic pathway may help maintain muscle creatine levels and limit cellular energy failure in leaky mdx skeletal muscles. These results may help better understand the mild phenotype of the mdx mouse and may offer new treatment horizons for DMD.
Figures







Similar articles
-
Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.Muscle Nerve. 2001 Nov;24(11):1468-75. doi: 10.1002/mus.1170. Muscle Nerve. 2001. PMID: 11745948
-
Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1.BMC Dev Biol. 2005 May 26;5:9. doi: 10.1186/1471-213X-5-9. BMC Dev Biol. 2005. PMID: 15918910 Free PMC article.
-
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17. Exp Physiol. 2014. PMID: 24443351
-
Creatine biosynthesis and transport in health and disease.Biochimie. 2015 Dec;119:146-65. doi: 10.1016/j.biochi.2015.10.022. Epub 2015 Nov 2. Biochimie. 2015. PMID: 26542286 Review.
-
Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?Amino Acids. 2016 Aug;48(8):1877-95. doi: 10.1007/s00726-016-2189-0. Epub 2016 Feb 10. Amino Acids. 2016. PMID: 26861125 Review.
Cited by
-
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.Neurobiol Dis. 2008 Jul;31(1):1-19. doi: 10.1016/j.nbd.2008.03.008. Epub 2008 Apr 9. Neurobiol Dis. 2008. PMID: 18499465 Free PMC article. Review.
-
Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.PLoS One. 2015 May 8;10(5):e0123336. doi: 10.1371/journal.pone.0123336. eCollection 2015. PLoS One. 2015. PMID: 25955839 Free PMC article.
-
¹³C NMR metabolomics: applications at natural abundance.Anal Chem. 2014 Sep 16;86(18):9242-50. doi: 10.1021/ac502346h. Epub 2014 Aug 29. Anal Chem. 2014. PMID: 25140385 Free PMC article.
-
Sil1-Mutant Mice Elucidate Chaperone Function in Neurological Disorders.J Neuromuscul Dis. 2016 May 27;3(2):169-181. doi: 10.3233/JND-160152. J Neuromuscul Dis. 2016. PMID: 27854219 Free PMC article.
-
Molecular analysis of stem cells and their descendants during cell turnover and regeneration in the planarian Schmidtea mediterranea.Cell Stem Cell. 2008 Sep 11;3(3):327-39. doi: 10.1016/j.stem.2008.07.002. Cell Stem Cell. 2008. PMID: 18786419 Free PMC article.
References
-
- Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50:509–517. - PubMed
-
- Nonaka I. Animal models of muscular dystrophies. Lab Anim Sci. 1998;48:8–17. - PubMed
-
- Watchko JF, O’Day TL, Hoffman EP. Functional characteristics of dystrophic skeletal muscle: insights from animal models. J Appl Physiol. 2002;93:407–417. - PubMed
-
- McArdle A, Edwards RH, Jackson MJ. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve. 1994;17:1378–1384. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources